Home

Perrigo (PRGO)

24.91
-0.02 (-0.08%)

Perrigo is a global healthcare company that specializes in the development, manufacturing, and distribution of over-the-counter (OTC) consumer products and pharmaceuticals

The company focuses on delivering affordable healthcare solutions, including dietary supplements, allergy medications, and personal care products. With a strong emphasis on quality and innovation, Perrigo aims to improve the health and well-being of its customers by providing accessible therapeutic options and effective alternatives to prescription medicines.

SummaryNewsPress ReleasesChartHistoricalFAQ
Insiders bet big on these turnaround stocks
Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead.
Via MarketBeat · December 28, 2023
SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON
Stolkholm’s Best Kept Skincare Secret Is The Perfect Gift For Giving
By ACO · Via GlobeNewswire · December 16, 2022
Is Sanofi A Buy, Despite Recent Stumbles?
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Via MarketBeat · August 19, 2022
Astaxanthin Market Expected to Exceed $1.2 Billion By 2026 Leading the Nutraceutical Segment for Lucrative Growth
Palm Beach, FL – July 1, 2021 Astaxanthin may be the most important, potent supplements that most people don’t even know exists.  Astaxanthin is a powerful, naturally occurring carotenoid pigment that’s found in certain marine plants and animals. It is this that causes the pink or red color in salmon, lobster, trout and seafood. Often called “the king of the carotenoids,” Astaxanthin is recognized as being one of the most powerful antioxidants found in nature. Antioxidants are essential for helping combat free radical and oxidative damage to help support a healthy aging process and boost immunity. People take Astaxanthin because of its valuable antioxidant properties. Astaxanthin is 800x stronger than CoQ10, 6,000x stronger than Vitamin C, and 100x stronger than Vitamin E when it comes to antioxidant activity. Astaxanthin helps improve cellular function, and has been linked to improving healthy blood flow, hypertension, improved cardiovascular health, immune health, joint pain, eye health, cognitive alertness and muscle recovery from exercise. Moreover, it has been linked to helping smooth wrinkles, make age spots smaller, and maintain skin moisture.   A report from Market Research Future said that because Astaxanthin is said to have many health values it is projected that the Astaxanthin Market is expected to register a CAGR of 7.7% to reach USD 1,206.52 Million by 2026. “It’s been linked to heart health, endurance, healthier skin, joint pain and may even be applied in future cancer treatment. As a result of this, astaxanthin finds usages in more than a few industries, counting food and beverages, pharmaceuticals, animal feed, and nutraceuticals.”    Active companies in the markets this week include: Pressure BioSciences, Inc. (OTCQB: PBIO), Cyanotech Corporation (NASDAQCYAN), Perrigo Company plc NYSE: PRGONYSEPRGO)(NYSE: MEDNYSEMED, Archer-Daniels-Midland Company (NYSE: ADMNYSE).
Via FinancialNewsMedia · July 1, 2021